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Abstract 
Background: Idiopathic scoliosis is a spinal deformity affecting approximately 3% of 
otherwise healthy children or adolescents. The etiology is still largely unknown but has an 
important genetic component. Genome-wide association studies have identified a number of 
common genetic variants that are significantly associated with idiopathic scoliosis in Asian 
and Caucasian populations, rs11190870 close to the LBX1 gene being the most replicated 
finding. 
Purpose: The aim of the present study was to investigate the genetics of idiopathic scoliosis in 
a Scandinavian cohort by performing a candidate gene study of four variants previously 
shown to be associated with idiopathic scoliosis and exome sequencing of idiopathic scoliosis 
patients with a severe phenotype to identify possible novel scoliosis risk variants. 
Study design: This was a case control study. 
Patient sample: A total of 1,739 patients with idiopathic scoliosis and 1,812 controls were 
included. 
Outcome measure: The outcome measure was idiopathic scoliosis. 
Methods: The variants rs10510181, rs11190870, rs12946942, and rs6570507 were genotyped 
in 1,739 patients with idiopathic scoliosis and 1,812 controls. Exome sequencing was 
performed on pooled samples from 100 surgically treated idiopathic scoliosis patients. Novel 
or rare missense, nonsense, or splice site variants were selected for individual genotyping in 
the 1,739 cases and 1,812 controls. In addition, the 5′UTR, noncoding exon and promoter 
regions of LBX1, not covered by exome sequencing, were Sanger sequenced in the 100 
pooled samples. 
Results: Of the four candidate genes, an intergenic variant, rs11190870, downstream of 
the LBX1 gene, showed a highly significant association to idiopathic scoliosis in 1,739 cases 
and 1,812 controls (p=7.0×10−18). We identified 20 novel variants by exome sequencing 
after filtration and an initial genotyping validation. However, we could not verify any 
association to idiopathic scoliosis in the large cohort of 1,739 cases and 1,812 controls. We 
did not find any variants in the 5′UTR, noncoding exon and promoter regions of LBX1. 
Conclusions: Here, we confirm LBX1 as a susceptibility gene for idiopathic scoliosis in a 
Scandinavian population and report that we are unable to find evidence of other genes of 
similar or stronger effect. 
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Introduction 
Idiopathic scoliosis is a spinal deformity affecting approximately 3% of otherwise healthy 
children or adolescents. In approximately 10% of the affected individuals, the deformity is 
progressive, requiring treatment with brace or spinal fusion surgery [1]. 
The etiology of idiopathic scoliosis is still largely unknown; heredity, however, is an 
important contributing factor [2,3]. Recent genome-wide association studies have identified 
common genetic variants close to, or within, the ladybird homeobox 1 (LBX1), cell adhesion 
molecule L1-like (CHL1), and G protein-coupled receptor 126 (GPR126) genes, as well as an 
intergenic variant on 17q, in Asian and Caucasian populations [4–7]. One exome sequencing 
study has identified novel, rare variants associated with idiopathic scoliosis in the Fibrillin 
1and 2 genes in a European population [8]. However, these variants explain only a small part 
of the heritability of this disorder. The aim of the present study was to investigate the genetics 
of idiopathic scoliosis in a Scandinavian cohort by performing a candidate gene study of 
variants previously shown to be associated with idiopathic scoliosis and exome sequencing of 
idiopathic scoliosis patients with a severe phenotype. 
Methods 
This is a Swedish and Danish multicenter case-control study. Five Swedish and 
one Danish orthopedic department participated: the Karolinska University Hospital, 
the Skåne University Hospital, the Sahlgren University Hospital, 
the Sundsvall and Härnösand County Hospital, and the University Hospital of Umeå, all 
in Sweden, and Middelfart Hospital, Denmark. 
Subjects and samples collection 
Cases 
Between 2004 and 2013, individuals with idiopathic scoliosis were invited to participate in 
the study. Details of the recruitment of patients have been published elsewhere [9–11]. 
Inclusion criteria were a juvenile or adolescent idiopathic scoliosis with a Cobb angle greater 
than or equal to 10° [12]. Only patients with a normal neurologic examination and without 
history or clinical sign of a non-idiopathic scoliosis were eligible for the study. A magnetic 
resonance imaging (MRI) was not mandatory for inclusion in the study, but all cases with an 
MRI of the spine showing neural abnormalities were excluded. In total, 4,404 patients were 
invited; 1,244 did not answer, 955 declined to participate, and 320 were excluded because of 
signs of nonidiopathic scoliosis, incomplete medical records, or age at onset less than 4 years 
of age, leaving 1,885 individuals for this study. Sampling and DNA extraction was successful 
in 1,739 patients, Table 1. 
  
Among the 1,739 patients, 495 were untreated, 641 were brace treated, and 603 were 
surgically treated. To allow for grading of the severity of the scoliosis, curve size was 
measured on routine radiographs from the occasion when the patient was considered to have 
the largest curve size: The last available radiograph before the age of 27 years in the untreated 
patients; on the last radiograph before bracing in the brace-treated patients; and on the 
preoperative radiograph in the surgically treated patients. Measurements were performed by 
the method by Cobb [12] and showed a mean (standard deviation) of 25 (12) for untreated, 33 
(8) for braced, and 57 (14) ° for operated patients. Curve location was defined according to 
the apex of the major curve; thoracic curves had an apex between the first and eleventh 
thoracic vertebrae, thoracolumbar curves between the twelfth thoracic and first lumbar 
vertebra, and lumbar curves from the second lumbar to fifth lumbar vertebrae. If an individual 
had two curves with a difference between the two measurements of less than 5°, the patient 
was defined as having a double primary curve. Individuals who were aged 4 to 9 years old at 
onset of scoliosis were defined as having juvenile idiopathic scoliosis. Of the patients, 1,485 
(85%) had parents who both were born in Scandinavia, 109 (6%) had one parent who was 
born in Scandinavia and one parent who was born outside Scandinavia, 113 (6%) had parents 
who were both born outside Scandinavia, and in 35 (2%), data on place of birth of parents 
were not available. 
DNA was prepared from blood in 98% and saliva in 2% of the samples. In 1,216 patients, a 
salt precipitation method on the Autopure LS system (Qiagen, Hilden, Germany) was used, 
and in 523 samples, the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany) was used for 
DNA extraction according to instructions from the manufacturer. 
From this cohort, 100 patients with a severe phenotype and Swedishancestry were chosen for 
exome sequencing, Table 1. Additional DNA was extracted with the Gentra Puregene Blood 
Kit (Qiagen, Hilden, Germany) according to instructions from the manufacturer. 
Concentration of the DNA was measured at least twice with the Qubit dsDNA BR Assay Kit 
(Thermo Fisher Scientific, Waltham, MA, USA). An equal amount of DNA from each subject 
was added to make 10 pools, with DNA from 10 patients in each pool. 
Controls 
Osteoporosis Prospective Risk Assessment (OPRA) and PEAK-25 cohorts 
Individuals from the population-based cohorts OPRA and PEAK-25 were used as 
controls [13,14]. The OPRA cohort consists of elderly women, and the PEAK-25 cohort 
consists of young women living in Malmö, Sweden. Deoxyribonucleic acid was available in 
2,011 individuals. In both these cohorts, dual-energy X-ray absorptiometry (DXA) for 
studying bone density had been part of the research protocol. Dual-energy X-ray 
absorptiometry has been reported to be a reliable method to evaluate scoliosis, comparable to 
conventional radiographs [15]. However, DXA is performed with the patient in a supine 
position, and the Cobb angle may be underestimated compared with standing radiographs. We 
therefore chose to exclude all individuals showing any sign of a curved spine on a whole body 
or lumbar spine DXA (n=199). We included those individuals missing DXA information 
(n=69), because the prevalence of idiopathic scoliosis in the normal population is 
low [1], leaving 1,812 individuals for this study, Table 1. 
In the 909 controls from the OPRA cohort, data on place of birth of parents were not 
available. All except three were born in Sweden. Place of birth is not specified for two 
individuals. In the 903 controls from the PEAK-25 cohort, 833 (92%) had parents who both 
were born in Scandinavia, 49 (5%) had one parent who was born in Scandinavia, and 21 (2%) 
had parents who both were born outside Scandinavia. Deoxyribonucleic acid was extracted 
using the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany) according to the 
instructions from the manufacturer. 
Control data for exome sequencing 
We used already existing anonymized exome sequencing data from 100 preeclampsia 
patients [16,17] and 100 patients with morbid obesity [18] as control data for the exome 
sequencing, Table 1. There is no phenotype information on scoliosis for these controls. The 
same pooling strategy, target enrichment, and sequencing platform as in the present study 
were used in both these cohorts. 
Candidate gene study 
Genotyping 
We genotyped the previously reported variants rs10510181, rs11190870, rs12946942, and 
rs6570507 in 1,739 patients with idiopathic scoliosis and in 1,812 controls from the OPRA 
and PEAK-25 cohorts [4–7]. Genotyping was performed at the Mutation Analysis Facility 
at Karolinska University Hospital (Huddinge, Sweden) using iPLEX Gold chemistry and 
MassARRAY mass spectrometry system (Agena Bioscience, San Diego, CA, USA) [19]. 
Multiplexed assays were designed using the MassARRAY Assay Design v4.0 Software 
(Sequenom, Agena Bioscience, San Diego, CA, USA). Genotype calls were manually 
checked by two persons individually using the MassARRAY Typer v4.0 Software (Agena 
BioScience, San Diego, CA, USA). 
Sequencing of LBX1 locus 
We found a strong association to rs11190870, approximately 6 kb downstream of 
the LBX1 gene. To further study the role of LBX1 in idiopathic scoliosis, we chose to 
sequence the LBX1 promoter and exon regions. There are two known transcripts of LBX1, 
one confirmed (NM_006562) and one predicted (XM_005269443), described in the Genome 
Reference Consortium, human reference 38, Figure S1. The coding regions of the confirmed 
transcript were covered by exome sequencing, in the following section. The predicted 
transcript (XM_005269443) of LBX1 contains an extra noncoding exon that was not covered 
by the exome sequencing target enrichment platform that we used. According to the 
FANTOM5 human promoter centric expression atlas, there are three transcription start sites 
(TSSs) of LBX1 and one TSS of the new LBX1isoform, detected in both adult and fetal 
skeletal muscle, Figure S2 [20]. To cover the new noncoding exon and the TSSs, we designed 
three primer pairs and performed polymerase chain reaction (PCR) amplification with 
HotStarTaq Plus DNA Polymerase kit (Qiagen, Hilden, Germany) on genomic DNA from the 
100 pooled samples used in exome sequencing, Table 1. PCR products were sequenced using 
cycle sequencing technology on ABI 3730XL sequencing machine at Eurofins Genomics 
(Ebersberg, Germany). 
Exome sequencing 
Exome sequencing was performed at the Science for Life laboratory, Stockholm, Sweden. 
Each DNA library was prepared from 3 µg of pooled genomic DNA sheared to 300 bp using a 
Covaris S2 instrument (Covaris, MA, USA) and enriched using the SureSelectXT Human All 
Exon 50 Mb (Agilent technologies, CA, USA) and an Agilent NGS workstation according to 
the manufacturer's instructions (SureSelectXT Automated Target Enrichment for Illumina 
Paired-End Multiplexed Sequencing, version A; Agilent technologies, CA, USA). 
Sequencing data analysis and variant selection 
Exome sequencing reads were aligned to the human reference genome hg19, Genome 
Reference Consortium Human Build 37, with the Burrows-Wheeler Aligner, BWA software 
package, version 0.6.1 (http://sourceforge.net/projects/bio-bwa/files/bwa-0.6.1.tar.bz2) [21]. 
We used SAMtools, version 
0.1.18 (http://sourceforge.net/projects/samtools/files/samtools/0.1.18/), to remove PCR 
duplicates on each lane, filter out reads with low mapping quality (Phred quality score <20), 
and call variants [22]. Both single and multiple pool calls were used. Annotation was 
completed using the ANNOVARsoftware (Biobase, Wolfenbuettel, Germany) [23]. We 
applied BEDTools, version 2.16.2 (http://bedtools.readthedocs.org/) for read depth and 
coverage evaluation [24]. 
We estimated the minor allele frequency of each variant by pooling all the reads at each 
position together and calculating the percentage of reads supporting the minor allele. We 
filtered out singleton variants and selected missense, nonsense, and splice site rare variants 
that had a minor allele frequency less than or equal to 0.05 in the 1000G project European 
population [25]. We compared our data with the exome sequencing data from the 100 
preeclampsia and the 100 obesity patients. We filtered out the variants that were found in 
more than one of the preeclampsia and obesity pools as likely innocent variants or sequencing 
errors. Among the remaining variants (n=353), we selected those that were related to skeleton, 
muscle or nervous system development, or cell adhesion (n=29) in the Gene Ontology 
Consortium database [26]. In addition, we checked the 353 variants by manual visualization 
and kept those not shown in obesity or preeclampsia patients at all (n=21). 
Variant validation and association analysis 
In an initial validation association analysis, 45 of the variants selected from the exome 
sequencing were successfully genotyped in 180 cases, including the previously exome 
sequenced subjects, and in 245 controls from the PEAK-25 cohort. In a follow-up, 20 of the 
variants with an odds ratio (OR) greater than or equal to 1.5 or less than or equal to 0.67 in the 
initial association analyses were genotyped in the remaining 1,567 cases and 1,567 controls 
from the OPRA and PEAK-25 cohorts. The same genotyping platform was used as described 
previously for the candidate gene study, Table S1. Finally, an association analysis combining 
the two data sets was performed. 
Statistical analysis 
Association was evaluated by the chi-square test using PLINK 
v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/) [27]. For subgroup analyses, curve severity 
was defined as mild if the patient had a Cobb angle of 10° to 30°, moderate if the patient had 
a Cobb angle of 31° to 44°, and severe if the patient had a Cobb angle greater than or equal to 
45°. Patients with a thoracic major curve with a right convexity were defined as “Right 
Thoracic” and patients with a thoracic major curve with a left convexity as “Left 
Thoracic.” The group “All Except Right Thoracic” includes all patients except those defined 
as “Right Thoracic.” Patients were subgrouped according to the age at onset in 4 to 8, 9 to 12, 
and 13 years and older, as well as in juvenile (4–9 years) and adolescent (10–20 years). 
 
Results 
Association analysis of candidate genes 
Of the four candidate genes, only an intergenic variant, rs11190870, downstream of 
the LBX1 gene, showed a strong association to idiopathic scoliosis in individual genotyping 
of cases and controls, Table 2. The other three variants showed weaker or no association. In 
subgroup analyses of the association of rs11190870, there seemed to be a stronger association 
with females than males, and with right thoracic curve types compared with all other curve 
types together, yielding higher point estimates for the ORs, Table 3. The curve severity and 
juvenile or adolescent age of onset did not appear to have a significant effect on the 
association, Table 3. However, comparisons between patient subgroups did not yield 
significant differences (data not shown). In addition, when comparing untreated, brace-treated 
and surgically treated individuals, we found no significant differences in association with the 
risk allele. 
We analyzed age at onset as a continuous outcome variable in a logistic regression of cases 
only and found no significant association with the risk allele (data not shown). In a subgroup 
analysis comparing age at onset 4 to 8 years, 9 to 12 years, and 13 years and older, we found 
no significant differences in association with the risk allele either (data not shown). 
Sequencing of LBX1 locus 
Because we observed a highly significant association of the previously 
identified LBX1 variant to scoliosis, we performed Sanger sequencing to discover further 
genetic variation at this locus. We did not find any variants in the 5′UTR, noncoding exon or 
promoter regions of LBX1, data not shown. 
Exome sequencing 
We obtained 307 to 418 million sequence reads in each sample pool, 93.3% to 98.5% of 
which could be mapped to the human reference genome hg19. Eighty-one to eighty -nine 
percent of the SureSelect target regions were covered by a depth of 30x. We identified a total 
of 1.7 million single nucleotide variants. After filtration and an initial genotyping validation, 
we selected 20 novel variants for further follow-up. We were, however, unable to find 
statistically significant association of any of these to idiopathic scoliosis in the large cohort of 
1,739 cases and 1,812 controls, Table S1. 
In the LBX1 exon region, we identified one synonymous variant, rs941909, in 6 of the 10 
pools in the idiopathic scoliosis patients and in 8 of the 10 pools in the preeclampsia patients, 
suggesting that it is a common innocent variant (data not shown). 
 
Discussion 
In a candidate gene study of four common single nucleotide variants previously shown to be 
associated with idiopathic scoliosis, we found a highly significant association of rs11190870, 
downstream of the LBX1 gene (p=7.0×10−18, OR 1.53) to idiopathic scoliosis, in a 
Scandinavian cohort of 1,739 idiopathic scoliosis cases and 1,812 controls. The other three 
variants showed weaker or no association. To identify novel high-risk variants contributing to 
scoliosis, we then performed exome sequencing on 100 pooled samples with a severe 
idiopathic scoliosis phenotype. Multiple variants were identified by exome sequencing, but 
we could not verify any association to idiopathic scoliosis by direct genotyping in the cohort 
of 1,739 cases and 1,812 controls. No new functional variant in the LBX1 gene was found. In 
addition, we Sanger sequenced the promoter region of LBX1 without identifying any variants. 
In a genome wide association study, Takahashi et al. [5] identified the common variant 
rs11190870 in the 10q24.31 region to be strongly associated with idiopathic scoliosis in a 
Japanese population of 1,033 cases and 1,473 controls with a p value and OR (1.2×10−19 and 
1.56, respectively) in parity with the present study. This association has subsequently been 
replicated in several North American and East Asian cohorts, suggesting the region on 
10q24.31 harboring the LBX1 gene, to be a true susceptibility locus for idiopathic 
scoliosis [28–30]. In this study, we found a highly significant association of rs11190870 to 
idiopathic scoliosis also in a Scandinavian population, and as such, confirm the association of 
the region 10q24.31 to idiopathic scoliosis across populations. 
Of the remaining three variants genotyped in our study, two showed a weak association to 
idiopathic scoliosis (rs6570507, p=1.6×10−4, OR 1.22 and rs12946942, p=.005, OR 1.27). 
The variant rs6570507 has previously been shown to be associated with idiopathic scoliosis in 
Japanese, Chinese Han, and European populations (p=1.27×10−14, OR 1.27) and rs12946942 
in a Japanese and Han Chinese population (p=6.43×10−12, OR=2.21) [4,6]. Our results lend 
support to the previously observed associations at a moderate level of genetic effect, but these 
variants do not appear to have a major effect on scoliosis risk in the Scandinavian population. 
Because of an obvious lack of power, we did not follow up subgroup associations to these 
three variants in the present study. 
LBX1 is expressed in dorsal spinal neurons and hindbrain, muscle precursor cells, and certain 
cardiac crest cells and is a plausible candidate in the pathogenesis of idiopathic scoliosis [31–
35]. In an attempt to further elucidate the potential role of LBX1 in idiopathic scoliosis, we 
used the FANTOM5 database to identify four putative TSSs of LBX1, detected in both adult 
and fetal skeleton muscles. We Sanger sequenced these regions in pooled DNA from 100 
surgically treated idiopathic scoliosis patients. We were, however, unable to identify any 
variants in these regions. 
The variant rs11190870 seems to be associated to idiopathic scoliosis irrespective of scoliosis 
curve severity [28–30]. This is supported by our findings, where we found no substantial 
differences in OR between mild, moderate, or severe scoliosis compared with controls. In a 
previous meta-analysis of several cohorts, Londono et al. [30] showed evidence for genetic 
susceptibility to scoliosis of rs11190870 in both males and females. In the current cohort, 
including the largest number of males reported, the point estimate of risk is higher in females, 
but not significantly different compared with that in males. In addition, the association of 
rs11190870 seems to be as strong in both adolescent and juvenile idiopathic scoliosis patients 
as well. 
Patients with idiopathic scoliosis have normal neurology and no signs of any disorders 
associated with scoliosis. However, MRI may reveal subclinical neural axis abnormalities in 
these patients. The most common curve type is a right convex thoracic scoliosis and it is most 
often associated with a normal neural axis MRI. On the other hand, neural axis malformations 
have been reported to be more common in left thoracic curves, and it may be speculated that 
these may represent another clinical entity [36,37]. Based on this, we hypothesized that the 
genetic basis could be different in patients with different curve types. In a subgroup analysis, 
we found that the association of rs11190870 seems to be stronger to right thoracic curves than 
all other curve types taken together (1.4×10−19, OR 1.68 and 5.4×10−5, OR 1.32, 
respectively) and to patients with left thoracic curves. The number of patients in the latter 
group is however very small, limiting the conclusions that can be drawn. To our knowledge, 
data on association with curve types have not been presented previously. 
The variants previously shown to be associated with idiopathic scoliosis, in other studies and 
ours, explain only a small part of the heritability of idiopathic scoliosis. To identify novel rare 
high-risk variants, we exome sequenced 100 pooled samples from individuals with a severe 
idiopathic scoliosis. The variants we identified were validated but were not strongly 
associated by individual genotyping in our large cohort of 1,739 and 1,812 controls. In 
addition, we could not find any putative functional variants in the LBX1 gene. In a recent 
exome sequencing study of a European population, rare variants in Fibrillin 1 and 2 were 
found to contribute to scoliosis [8]. We could not replicate these findings (data not shown). 
This might be due to different population background or different selection of subgroups of 
scoliosis individuals. 
A limitation of the pooled exome sequencing strategy is the need for filtering. Variants found 
in only one pool and variants with a very low frequency, despite being found in several pools, 
were removed to avoid false positives. One might question the use of exome sequencing data 
from morbidly obese and preeclampsia patients without any scoliosis phenotype information 
as control data. However, the prevalence of scoliosis is low in the general population, and an 
above-normal BMI is shown to be protective against spinal deformities [38]. Another 
limitation is the difficulty of finding association by genotyping of the variants identified by 
exome sequencing. This might be due to a lack of power in the follow-up, looking for rare 
variants demands large sample sizes to reach significance. 
In conclusion, we confirm LBX1 as a susceptibility gene for idiopathic scoliosis in a 
Scandinavian population and do not find evidence of other scoliosis risk genes of similar or 
stronger effect. In the future, possible strategies to succeed in elucidating the role of 
the LBX1 region and discovering new risk factors for adolescent idiopathic scoliosis, include 
metastudies, detailed studying of subphenotypes, family studies, and epigenetic approaches. 
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Tables 
Table 1. Summary of samples used in association analysis and exome sequencing 
 
 Association analysis Exome sequencing 
Cases Controls Cases Control data 
set 
(preeclampsia) 
Control data 
set (obesity) 
Sample size 1,739 1,812 100 100 100 
Gender(male/female) 241/1,498 0/1,812 24/76 0/100 31/69 
Cobb Angle 
(Mean±SD) 
38.8±17.5*  56.3±13.2   
 
SD, standard deviation. 
*Missing data on Cobb angles in 11 individuals. 
 
Table 2. Association of candidate genes to idiopathic scoliosis in a Scandinavian cohort of 
1,739 cases and 1,812 controls. 
 
Variant 
name 
Gene A1 A2 RAF 
cases 
RAF 
controls 
p Value OR (95% CI) 
rs6570507 GPR126intron A G 0.32 0.28 1.6×10−4 1.22(1.10–1.35) 
rs11190870 LBX1downstream T C 0.69 0.59 7.0×10−18 1.53(1.39–1.69) 
rs12946942 Intergenic T G 0.09 0.08 .005 1.27(1.08–1.51) 
rs10510181 CHL1upstream A G 0.36 0.36 .97 1.0(0.91–1.1) 
 
A1, allele 1 (risk allele); A2, allele 2; RAF, risk allele frequency; OR, odds ratio; CI, confidence 
interval; GPR126, G protein-coupled receptor; LBX1,ladybird homeobox 1; CHL1, cell adhesion 
molecule L1-like. 
 
  
Table 3. Associations of rs11190870, downstream the LBX1 gene, to subgroups of idiopathic 
scoliosis cases. The same number of controls is used in all analyses (n=1812). 
 
Subgroup n Risk 
allele 
RAF 
cases 
RAF 
controls 
p Value OR 95% CI 
All 1,739 T 0.69 0.59 7.0×10−18 1.53 1.39 to 1.69 
Females 1,498 T 0.69 0.59 8.2×10−18 1.56 1.41 to 1.73 
Males 241 T 0.66 0.59 .001 1.38 1.13 to 1.68 
Right Thoracic 
curve 
1,107 T 0.71 0.59 1.4×10−19 1.68 1.50 to 1.88 
Left Thoracic 74 T 0.64 0.59 .17 1.27 0.90 to 1.79 
All except Right 
Thoracic* 
603 T 0.66 0.59 5.4×10−5 1.32 1.15 to 1.50 
Juvenile onset 213 T 0.69 0.59 3.7×10−5 1.57 1.27 to 1.95 
Adolescent onset 1,526 T 0.69 0.59 1.6×10−16 1.53 1.38 to 1.69 
Mild (10–30)† 616 T 0.67 0.59 1.9×10−7 1.43 1.25 to 1.64 
Moderate (31–44)† 527 T 0.70 0.59 6.6×10−11 1.63 1.41 to 1.89 
Severe (45–)† 585 T 0.69 0.59 4.5×10−10 1.56 1.36 to 1.80 
 
RAF, risk allele frequency; OR, odds ratio; CI, confidence interval. 
*The group “All except Right Thoracic” includes the “Left Thoracic” group. Missing data on curve 
type in 29 individuals. 
†Curve severity and Cobb angle of the largest curve. Missing data in 11 individuals. 
  
Supplementary material  
 
Table S1. Oligonucleotide primers used for PCR amplification of LBX1 promoter regions 
 
#primer	   Sequence	   Orientation	   Amplicon	  length	  (bp)	   GC	  contents	  
1	   5’	  -­‐	  GCCTTGCCGTCCTCCTTG	  -­‐	  3’	   sense	   444	   75.68	  %	  5’	  -­‐	  AATTGCCCCGTCTCTCCG	  -­‐	  3’	   antisense	  
2	   5’	  -­‐	  TAAAGGTGTCAGGTGGCTCG	  -­‐	  3’	   sense	   512	   57.42	  %	  5’	  -­‐	  AGGTTCGGGTGCAATAAAGG	  -­‐	  3’	   antisense	  
3	   5’	  -­‐	  GAGAGCTCAGCCTTCTCCAC	  -­‐	  3’	   sense	   395	   72.92	  %	  5’	  -­‐	  CGAGTTCCTGAGAGCAAAGC	  -­‐	  3’	   antisense	  
 
 
Table S2. Scoliosis pooled DNA exome sequencing mapping statistic 
 
Pooled	  sample	   Uniquely	  mapped	  reads	  (PCR	  duplicate	  removed)	  
Pool1	   111,199,355	  
Pool2	   138,036,076	  
Pool3	   115,158,113	  
Pool4	   127,845,939	  
Pool5	   119,736,656	  
Pool6	   103,399,069	  
Pool7	   83,341,128	  
Pool8	   68,241,716	  
Pool9	   102,034,437	  
Pool10	   112,423,514	  
 
 
 
 
 
  
Table S3. Association analysis of 20 variants identified by exome sequencing 
SNP A1 A2 F_A F_U P OR 
rs3795424 G T 0.03385 0.02956 0.3017 1.15 
rs41265897 A G 0.04102 0.03333 0.087 1.241 
rs74857529 G C 0.006613 0.004171 0.1601 1.589 
rs141826063 A G 0.002009 0.0008338 0.1879 2.413 
rs34372645 A G 0.02583 0.02309 0.4557 1.122 
rs41272699 T C 0.02183 0.0172 0.1591 1.275 
rs61734638 A G 0.03096 0.02998 0.8103 1.034 
rs106287 A G 0.01696 0.02139 0.1752 0.7895 
rs61748674 A G 0.0218 0.02627 0.2192 0.826 
rs41279597 C T 0.03129 0.02361 0.04785 1.336 
rs2437100 A G 0.02411 0.02585 0.6396 0.9311 
rs11575580 T C 0.01263 0.01051 0.4032 1.204 
rs150621117 G A 0.01406 0.01444 0.8927 0.9733 
rs76708142 C T 0.009466 0.009439 0.9905 1.003 
rs118105704 G A 0.02875 0.02738 0.7261 1.052 
rs141855950 C T 0.006024 0.00221 0.0117 2.736 
rs63750072 G A 0.04744 0.04712 0.9488 1.007 
rs55780333 A G 0.1117 0.09712 0.04432 1.169 
rs144151494 C T 0.004303 0.003057 0.3861 1.409 
rs1800273 A G 0.04426 0.03929 0.3044 1.132 
A1: major allele 
A2: minor allele 
F_A: frequency of minor allele in cases 
F_U: frequency of minor allele in controls 
OR: odds ratio 
Table S4. Primers for genotyping 
SNP_ID	   2nd-­‐PCRP	  (PCR	  primer	  reverse)	   1st-­‐PCRP	  (PCR	  primer	  forward)	   UEP_SEQ	  (extension	  primer)	  
rs74857529	   ACGTTGGATGAGGACCCCCATTTTACTTC	   ACGTTGGATGTCTGCTGTTTGAGAAGATGG	   TCTTCCCGCCTTACCCT	  
rs2437100	   ACGTTGGATGAGTCACCTGTCGGTCTGGTC	   ACGTTGGATGATAGACTTGCTGAGCAGCAC	   GCCGTGACGCATGACCC	  
rs41265897	   ACGTTGGATGTGCAGAGTTCACACTCTGGG	   ACGTTGGATGTCCTACCGCACATGTCTCTC	   TTGAGGAGCTGGGCTGCT	  
rs76708142	   ACGTTGGATGGGTTGACCAGTTCACAAGAC	   ACGTTGGATGTCTATAGCTGACTTGGCTCG	   AACACATCTGCCCTTGATA	  
rs141826063	   ACGTTGGATGCATCCCCTAATCAACATACC	   ACGTTGGATGAGGAATCCCACTGTAAGATG	   ACCTGTGCAAACTTCATAG	  
rs12946942	   ACGTTGGATGGAATGTTTGGGCATGGAGAG	   ACGTTGGATGCCAAACAATGCCTTCATCCC	   GTTTCATTGAGTTAGACTGG	  
rs144151494	   ACGTTGGATGTGACTTCAGAGGGAGACAAG	   ACGTTGGATGGAACCCCTAGATTCTCTAAG	   ACAAGCCCCCAAGACTGTCTG	  
rs150621117	   ACGTTGGATGACCAGCAGCATAAGGCCTAT	   ACGTTGGATGAGCCAGAAGTACTCAATGGG	   GCATAAGGCCTATTAAATCCA	  
rs41279597	   ACGTTGGATGTGCTGGCCTAGATGATAACC	   ACGTTGGATGAAATGAGGCTCAGGACAATG	   AGGCAGAGAAAATGCTTACCTG	  
rs61734638	   ACGTTGGATGCACTGGAAGTCATTCACGC	   ACGTTGGATGAGCGCTAATCGTCATTGAGG	   CTGGAAGTCATTCACGCTGACCA	  
rs34372645	   ACGTTGGATGACTCGAGTATGCAGTCGGTG	   ACGTTGGATGCAAAGTGACGGACCTGGATG	   CCTGCACACGGCGTCTCCTCCACA	  
rs106287	   ACGTTGGATGGGTGATGGCAGCCATATCTC	   ACGTTGGATGCTGCTCTCCCCTTTTCACAG	   ATATCTCCTGGCTGGAGCTTGACCA	  
rs41272699	   ACGTTGGATGTGCAGGAGGAGATTCAGTTG	   ACGTTGGATGCATGCAAGGGGAAAAGAAGG	   GAGAACAATTTGGCTGCCTTCCGAG	  
rs11575580	   ACGTTGGATGACTGAGGCCAAGAACCCAG	   ACGTTGGATGGAGACAGCTGCCTTTCTATG	   TCCATCCTTCCCACCCC	  
rs11190870	   ACGTTGGATGATATGGAGCTGTTTGCCTGC	   ACGTTGGATGCCAACACCAGAGGAATTATC	   GTTTGCCTGCGATTTGC	  
rs10510181	   ACGTTGGATGCAAATGTGTAGGAATAGCAG	   ACGTTGGATGGAGACCAACGTCTACTTAAGA	   AGGAATAGCAGAGGGTC	  
rs55780333	   ACGTTGGATGACGGACTCCCAAATCCTCT	   ACGTTGGATGCACAAGGAAGCCTTCTTCAG	   CCAAATCCTCTCATGAAC	  
rs1800273	   ACGTTGGATGCCCAGTTGCATTCAATGTTC	   ACGTTGGATGTACAGGAACTCCAGGATGGC	   GTTCTGACAACAGTTTGCC	  
rs141855950	   ACGTTGGATGATGCTCCCTCTGAACCACTG	   ACGTTGGATGGGAAGACAGACTAGAAGCAC	   TGAACCACTGAAAGCTGTG	  
rs61748674	   ACGTTGGATGTGATGGTAGATGGGTCGATG	   ACGTTGGATGTAAGACTGATCCGAGCACAC	   AGATGGGTCGATGTCGAGA	  
rs63750072	   ACGTTGGATGGCTTCTCTGGCGGCTGTCT	   ACGTTGGATGAAGACCGCGACGTCGATGAG	   CTTGGAGGGAGGGGAGTCT	  
rs3795424	   ACGTTGGATGAGTATGAGCCTCAGTTCCTG	   ACGTTGGATGGTTCTCTGCAGAGCTTTGG	   CTCAGTTCCTGCGGCTCCTAG	  
rs6570507	   ACGTTGGATGAGCAGTTAGGCTCACTTCAG	   ACGTTGGATGAACTTAGCAGTCACAGTGGC	   GAATTCAGTCCTTGTAGAATAA	  
rs118105704	   ACGTTGGATGTCCTAGCCCTCCTTATGGTC	   ACGTTGGATGCGATTCTCCCAAACTCTTG	   TCATATGGAAACACATCTCCTTC	  
Figure S1. LBX1 promoter region 
